- Home
- PULM vs CLPS Comparison
PULM vs CLPS Comparison
Compare PULM & CLPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- CLPS
- Stock Information
- Founded
- PULM 2003
- CLPS 2005
- Country
- PULM United States
- CLPS Hong Kong
- Employees
- PULM N/A
- CLPS N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- CLPS Computer Software: Prepackaged Software
- Sector
- PULM Health Care
- CLPS Technology
- Exchange
- PULM Nasdaq
- CLPS Nasdaq
- Market Cap
- PULM 28.3M
- CLPS 26.3M
- IPO Year
- PULM N/A
- CLPS 2018
- Fundamental
- Price
- PULM $8.90
- CLPS $0.94
- Analyst Decision
- PULM
- CLPS
- Analyst Count
- PULM 0
- CLPS 0
- Target Price
- PULM N/A
- CLPS N/A
- AVG Volume (30 Days)
- PULM 20.6K
- CLPS 8.9K
- Earning Date
- PULM 05-15-2025
- CLPS 03-05-2025
- Dividend Yield
- PULM N/A
- CLPS 13.69%
- EPS Growth
- PULM N/A
- CLPS N/A
- EPS
- PULM N/A
- CLPS N/A
- Revenue
- PULM $1,921,000.00
- CLPS $153,816,045.00
- Revenue This Year
- PULM N/A
- CLPS N/A
- Revenue Next Year
- PULM $134.88
- CLPS N/A
- P/E Ratio
- PULM N/A
- CLPS N/A
- Revenue Growth
- PULM N/A
- CLPS 5.81
- 52 Week Low
- PULM $1.78
- CLPS $0.68
- 52 Week High
- PULM $10.40
- CLPS $1.70
- Technical
- Relative Strength Index (RSI)
- PULM 69.72
- CLPS 40.49
- Support Level
- PULM $7.94
- CLPS $0.94
- Resistance Level
- PULM $9.37
- CLPS $1.05
- Average True Range (ATR)
- PULM 0.66
- CLPS 0.05
- MACD
- PULM 0.30
- CLPS -0.00
- Stochastic Oscillator
- PULM 88.69
- CLPS 7.69
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.